Home>Topics>>Recent Catalysts For Peregrine Pharmaceuticals
Recent Catalysts For Peregrine Pharmaceuticals
Healthcare Sector and Stocks Analysis from Seeking Alpha
Fri, 7 Dec 2012
By WM Analyst : Peregrine Pharmaceuticals (NASDAQ: PPHM ) is a biopharmaceutical company that develops monoclonal antibodies for the treatment and diagnosis of cancer. The company has an extensive pipeline including PS-targeting antibodies and DNA/histone-targeting antibodies. Bavituximab is the ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.